Abstract
The pharma industry’s adaptation to Industry 4.0 has been slow, due to the extensive regulatory requirements imposed on manufacturers. However, regulatory agencies are starting to embrace movement towards more rapid/automated systems, as illustrated in the revised EU GMP Annex 1, which is due to enter into force in August. Here, Isabella Jul-Jørgensen from the Technical University of Denmark and Novo Nordisk delves into advances in rapid and automated environmental monitoring systems.
| Original language | English |
|---|---|
| Journal | European Pharmaceutical Review |
| Volume | 28 |
| Issue number | 4 |
| Pages (from-to) | 10-15 |
| ISSN | 1759-1279 |
| Publication status | Published - 2023 |